Migraine Disorders
Conditions
Interventions
This is a parallel, randomized, placebo-controlled clinical trial to evaluate pain thresholds before and after the inhalation of essential oils or a control, in patients of both genders diagnosed with
Sponsors
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Eligibility
Age
18 Years to 60 Years
Inclusion criteria
Inclusion criteria: Volunteers of all genders; aged between 18 and 60 years; mentally competent; diagnosed with chronic or episodic migraine; with or without prophylactic medication; according to the International Classification of Headache Disorders criteria
Exclusion criteria
Exclusion criteria: Volunteers with severe acute circulatory disorders; diabetes mellitus; uncontrolled arterial hypertension; fibromyalgia; cognitive impairments; anosmia or hyposmia after COVID-19; allergy to substances present in essential oils; pregnancy and lactation
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| It is expected that the pain thresholds of migraine patients after inhaling essential oils will be higher than the pre-intervention thresholds and higher than those observed in the control group | — |
Secondary
| Measure | Time frame |
|---|---|
| It is expected that the perceived pleasantness after the inhalation of essential oils will be correlated with variations in pain thresholds | — |
Countries
Brazil
Contacts
Public ContactMario Peres
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
Outcome results
None listed